Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | Chief Medical Officer | Restricted Stock Units | 22K | $220K | $10.00 | Feb 14, 2024 | Direct |
Verve Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 90K | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Chief Medical Officer |
VERV | Verve Therapeutics, Inc. | Sep 18, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Chief Medical Officer |
VERV | Verve Therapeutics, Inc. | Sep 18, 2023 | 0 | $0 | 3 | Sep 19, 2023 | Chief Medical Officer |